Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R. Feld
Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib, Erlotinib, Afatinib, Dacomitinib, and Icotinib in the Treatment of Non-Small-Cell Lung Cancer: A Systematic Review
Current Oncology
Oncology
Adjuvant Chemoradiation for Gastric Cancer With Infusional 5-Fluorouracil and Cisplatin: A Phase I Study
Current Oncology
Oncology
Related publications
The Treatment of Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non-Small-Cell Lung Cancer to Gefitinib
Yearbook of Pulmonary Disease
The Role of Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer
Dicle Medical Journal / Dicle Tip Dergisi
Effectiveness and Cost-Effectiveness of Erlotinib Versus Gefitinib in First-Line Treatment of Epidermal Growth Factor Receptor–activating Mutation-Positive Non–small-Cell Lung Cancer Patients in Hong Kong
Hong Kong Medical Journal
Medicine
Somatic Mutations of the Epidermal Growth Factor Receptor and Non-Small-Cell Lung Cancer
Journal of Medical Genetics
Genetics
Enhancement of Epidermal Growth Factor Receptor-Degradation Pathway in Acquired Gefitinib-Resistant Human Non-Small Cell Lung Cancer Cell Lines
The Showa University Journal of Medical Sciences
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non–Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor
JAMA - Journal of the American Medical Association
Medicine
Comparison of Clinical Outcomes Following Gefitinib and Erlotinib Treatment in Non–Small-Cell Lung Cancer Patients Harboring an Epidermal Growth Factor Receptor Mutation in Either Exon 19 or 21
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Chemotherapy-Induced Epidermal Growth Factor Receptor Activation Determines Response to Combined Gefitinib/Chemotherapy Treatment in Non-Small Cell Lung Cancer Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
